← Back to Search

Monoclonal Antibodies

DLX105-DMP Multi-Dose Twice Weekly for Plaque Psoriasis

Phase 1
Waitlist Available
Research Sponsored by DelArrivo, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1, day 15, and day 25
Awards & highlights

Study Summary

This trial is testing a new medication for plaque psoriasis. The medication is given for four weeks to see if it is safe and effective.

Eligible Conditions
  • Plaque Psoriasis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1, day 15, and day 25
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1, day 15, and day 25 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adverse Events
Local Investigator Global Assessment (IGA)
Local Psoriasis Area Severity Index Sum of Scores (Local PASI SOS)
+2 more
Secondary outcome measures
Immunogenicity Testing
Pharmacokinetic Parameters

Trial Design

2Treatment groups
Experimental Treatment
Group I: DLX105-DMP Multi-Dose Twice WeeklyExperimental Treatment1 Intervention
4 Weeks of 1mg DLX105-DMP applied to a target lesion twice weekly
Group II: DLX105-DMP Multi-Dose Once WeeklyExperimental Treatment1 Intervention
4 Weeks of 1mg DLX105-DMP applied to a target lesion once weekly
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
DLX105-DMP
2022
Completed Phase 1
~10

Find a Location

Who is running the clinical trial?

DelArrivo, Inc.Lead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Study of DLX105-DMP in Subjects With Plaque Psoriasis
2022. "A Study of DLX105-DMP in Subjects With Plaque Psoriasis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04203433.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top